Abstract
The effect of antioxidant compounds ionol and mexidol and the new phenol derivative N9-imidazo-(1,2 alpha)-benzymidazol (PY-185) on the functional activity of blood platelets was studied. All the compounds under study effectively inhibited blood platelet aggregation both in vitro and in administration into rats, a result of which the blood thrombogenic potential reduced.
MeSH terms
-
Animals
-
Antioxidants / pharmacology*
-
Benzimidazoles / pharmacology
-
Butylated Hydroxytoluene / pharmacology
-
Humans
-
Imidazoles / pharmacology
-
Picolines / pharmacology
-
Platelet Aggregation / drug effects*
-
Platelet Aggregation Inhibitors / pharmacology*
-
Platelet Count / drug effects
-
Rabbits
-
Rats
-
Thrombelastography
Substances
-
Antioxidants
-
Benzimidazoles
-
Imidazoles
-
N(9)-imidazo-(1,2)-benzimidazol
-
Picolines
-
Platelet Aggregation Inhibitors
-
Butylated Hydroxytoluene
-
emoxypine succinate